EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

A retrospective cohort study of monthly rifampicin, ofloxacin and minocycline in the management of leprosy at the Hospital for Tropical Diseases, London, United Kingdom

Priyanka Sivakumaran iD, Barbara de Barros, Vivianne Lopes Antonio Dias, Diana N Lockwood, Stephen L Walker

PLOS Neglected Tropical Diseases · 2024

DOI: 10.1371/journal.pntd.0012699 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift PLOS Neglected Tropical Diseases, 2024. Verfasst von Priyanka Sivakumaran und 4 weiteren Autor:innen. Beteiligte Einrichtung: Royal London Hospital, London, United Kingdom. Hauptthemen laut MEDLINE: Leprosy, Rifampin, Minocycline, Leprostatic Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hospital for Tropical Diseases Charitable Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The World Health Organization (WHO) recommends rifampicin, dapsone and clofazimine multi-drug therapy (MDT) for the treatment of leprosy. Severe adverse effects include dapsone hypersensitivity syndrome, skin pigmentation, haemolytic anaemia, and hepatitis. At the Hospital for Tropical Diseases (HTD), London, United Kingdom monthly rifampicin, ofloxacin and minocycline (mROM) is used as first line treatment for leprosy.

Objectives

To determine the clinical outcomes and experiences of individuals treated with mROM.

Methods

A retrospective study of individuals with leprosy who were prescribed mROM at HTD was conducted. Demographic and clinical data were collected on outcomes including relapses, leprosy reactions, bacterial index (BI) and adverse effects. Individuals were interviewed using a semi-structured questionnaire to understand their experiences of mROM.

Results

29 individuals were identified and 20 interviewed. 26 (89.7%) individuals completed monthly mROM. 9 (31%) had switched from WHO MDT to mROM (five of whom (55.6%) were interviewed). BI reduced significantly following mROM treatment (p = 0.04). 17 individuals (58.6%) experienced a leprosy reaction. One of the 29 (3.4%) relapsed. The relapse rate was 9.5/1000 person years. 49 reports of adverse effects were either mild or moderate. The most frequent adverse effect (14/49) reported was orange discolouration of urine. No adverse effect required hospitalisation or discontinuation of mROM. Most individuals reported that skin lesions improved by the time they had completed mROM.

Conclusions

In this small study in a non-endemic setting mROM was safe, effective and acceptable. mROM therapy is associated with improvement in skin lesions, decline in bacterial index and acceptable adverse effects. Larger, prospective, randomised studies are needed to determine whether relapse rates with mROM are equivalent or better than WHO MDT and to provide robust data on the seemingly better adverse effect profile of mROM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LeprosyRifampinMinocyclineLeprostatic AgentsDrug Therapy, CombinationHumansRetrospective StudiesMaleFemaleAdultMiddle AgedLondonYoung AdultAgedTreatment OutcomeAdolescent

Substanzen

RifampinMinocyclineLeprostatic Agents

Autor:innen und Institutionen

  • Royal London Hospital, London, United Kingdom.
  • Hospital for Tropical Diseases, University College London Hospitals NHS Foundation Trust, London, United Kingdom.
  • Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Universidade Federal Fluminense, Rio de Janeiro, Brazil.
  • Department of Dermatology, University College London Hospitals NHS Foundation Trust, London, United Kingdom.

ORCID-Profile: Priyanka Sivakumaran

Förderung

  • Hospital for Tropical Diseases Charitable Fund

Zitieren

APA

Sivakumaran, P., Barros, B., Antonio Dias, V. L., Lockwood, D. N., & Walker, S. L. (2024). A retrospective cohort study of monthly rifampicin, ofloxacin and minocycline in the management of leprosy at the Hospital for Tropical Diseases, London, United Kingdom. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0012699

Vancouver

Sivakumaran P, Barros B, Antonio Dias VL, Lockwood DN, Walker SL. A retrospective cohort study of monthly rifampicin, ofloxacin and minocycline in the management of leprosy at the Hospital for Tropical Diseases, London, United Kingdom. PLOS Neglected Tropical Diseases. 2024. doi:10.1371/journal.pntd.0012699

BibTeX
@article{Sivakumaran2024,
  author = {Sivakumaran, Priyanka and Barros, Barbara de and Antonio Dias, Vivianne Lopes and Lockwood, Diana N and Walker, Stephen L},
  title = {A retrospective cohort study of monthly rifampicin, ofloxacin and minocycline in the management of leprosy at the Hospital for Tropical Diseases, London, United Kingdom},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2024},
  doi = {10.1371/journal.pntd.0012699}
}
Kostenlos starten →